Perspective Therapeutics (CATX) Return on Capital Employed Growth (3y) (2016 - 2026)
Perspective Therapeutics (CATX) Return on Capital Employed Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -1,962.00 |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 214.00 |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 31.00 |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 355.00 |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -846.00 |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -247.00 |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 1,318.00 |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 362.00 |
| 10 | Perspective Therapeutics | 306.67 Mn | 306.67 Mn | - | -1,372.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,372.00 |
| Dec 31, 2025 | -2,175.00 |
| Sep 30, 2025 | -2,640.00 |
| Jun 30, 2025 | -2,393.00 |
| Mar 31, 2025 | -2,483.00 |
| Dec 31, 2024 | -2,109.00 |
| Sep 30, 2024 | -1,219.00 |
| Jun 30, 2024 | -1,369.00 |
| Mar 31, 2024 | -1,692.00 |
| Dec 31, 2023 | -1,438.00 |
| Sep 30, 2023 | 1,650.00 |
| Jun 30, 2023 | 2,246.00 |
| Mar 31, 2023 | 2,231.00 |
| Dec 31, 2022 | 2,614.00 |
| Sep 30, 2022 | 4,072.00 |
| Jun 30, 2022 | 4,744.00 |
| Mar 31, 2022 | 5,944.00 |
| Dec 31, 2021 | 5,554.00 |
| Sep 30, 2021 | 7,262.00 |
| Jun 30, 2021 | 10,970.00 |